Stockscreener 앱 받기
9.12
0.66%
-0.04
전일 마감가:
$9.16
열려 있는:
$9.17
하루 거래량:
67,180
Relative Volume:
0.07
시가총액:
$964.15M
수익:
$247.00M
순이익/손실:
$-249.00M
주가수익비율:
-2.9515
EPS:
-3.09
순현금흐름:
$-267.00M
1주 성능:
-7.61%
1개월 성능:
+7.44%
6개월 성능:
-32.14%
1년 성능:
-39.53%
1일 변동 폭
$8.99
$9.30
1주일 범위
$8.84
$9.925
52주 변동 폭
$6.50
$18.98
Arcus Biosciences Inc Stock (RCUS) Company Profile
명칭
Arcus Biosciences Inc
전화
(510) 694-6200
주소
3928 POINT EDEN WAY, HAYWARD, CA
RCUS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RCUS
Arcus Biosciences Inc
|
9.1056 | 969.91M | 247.00M | -249.00M | -267.00M | -3.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
467.63 | 118.67B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.13 | 59.23B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
417.01 | 52.67B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
678.97 | 41.24B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
302.50 | 32.36B | 3.81B | -644.79M | -669.77M | -6.24 |
Arcus Biosciences Inc Stock (RCUS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-26 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2024-10-21 | 개시 | H.C. Wainwright | Neutral |
| 2024-10-08 | 개시 | Wells Fargo | Overweight |
| 2022-11-18 | 개시 | BofA Securities | Neutral |
| 2022-10-11 | 개시 | Morgan Stanley | Overweight |
| 2021-10-15 | 재개 | BTIG Research | Buy |
| 2020-11-24 | 개시 | Berenberg | Buy |
| 2020-11-23 | 개시 | Evercore ISI | Outperform |
| 2020-04-03 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-03-04 | 개시 | Barclays | Overweight |
| 2019-11-12 | 개시 | SunTrust | Buy |
| 2019-09-27 | 개시 | Mizuho | Buy |
| 2019-05-24 | 재개 | Citigroup | Buy |
| 2018-10-09 | 개시 | Wedbush | Outperform |
| 2018-04-09 | 개시 | Citigroup | Buy |
| 2018-04-09 | 개시 | Goldman | Neutral |
| 2018-04-09 | 개시 | Leerink Partners | Outperform |
모두보기
Arcus Biosciences Inc 주식(RCUS)의 최신 뉴스
When is Arcus Biosciences Inc. stock expected to show significant growthIdentify undervalued stocks ready to soar - jammulinksnews.com
How volatile is Arcus Biosciences Inc. stock compared to the marketTremendous gains - jammulinksnews.com
What are the technical indicators suggesting about Arcus Biosciences Inc.Free Wealth Planning Blueprint - jammulinksnews.com
What institutional investors are buying Arcus Biosciences Inc. stockHigh-yield investments - jammulinksnews.com
Should I hold or sell Arcus Biosciences Inc. stock in 2025Unlock powerful portfolio management tools - jammulinksnews.com
How does Arcus Biosciences Inc. compare to its industry peersOutstanding capital appreciation - jammulinksnews.com
What are the latest earnings results for Arcus Biosciences Inc.Outstanding risk-reward balance - jammulinksnews.com
Why is Arcus Biosciences Inc. stock attracting strong analyst attentionRealize consistent double-digit growth - jammulinksnews.com
Does Arcus Biosciences Inc. stock perform well during market downturnsTremendous gains - jammulinksnews.com
What catalysts could drive Arcus Biosciences Inc. stock higher in 2025Free Stock Movement Tracking - jammulinksnews.com
Arcus Biosciences’ Pancreatic Cancer Drug Quemliclustat Receives Orphan Drug Designation from FDA - MSN
How does Arcus Biosciences Inc. generate profit in a changing economyPost Market Planner That Work - jammulinksnews.com
Will Arcus Biosciences Inc. bounce back from current supportEarly Breakout Entry Point Notifications Sent - metal.it
Why Arcus Biosciences Inc. stock attracts strong analyst attentionConsistent Income Focused Trade List Analyzed - beatles.ru
How many analysts rate Arcus Biosciences Inc. as a “Buy”Advanced Screener Report With Low Risk - jammulinksnews.com
Arcus Biosciences Inc.’s Price Action Aligns with Quant SignalsHigh Yield Stock Screening Results Explained - metal.it
Arcus Biosciences’ SWOT analysis: HIF-2alpha program drives stock outlook By Investing.com - Investing.com South Africa
Arcus Biosciences’ SWOT analysis: HIF-2alpha program drives stock outlook - Investing.com
Arcus Biosciences Inc. Shows Risk Reward Favoring UpsideReal Trader Watchlist of Hot Stocks Released - metal.it
Is it the right time to buy Arcus Biosciences Inc. stockSuperior returns - jammulinksnews.com
What is Arcus Biosciences Inc. company’s growth strategyMaximize your portfolio’s growth potential - jammulinksnews.com
New Product Launches: Will They Boost Arcus Biosciences Inc. Stock in 2025Professional Stock Screener - metal.it
What is the dividend policy of Arcus Biosciences Inc. stockGet daily updates on the hottest stocks - jammulinksnews.com
Arcus Biosciences Inc. Company’s Quarterly Earnings Growth: What the Numbers SayInvestor Favorite Picks - metal.it
How Interest Rate Changes Impact Arcus Biosciences Inc. Stock PerformanceFree Stock Market Beginners Guide - Newser
Arcus Biosciences Inc. Stock Support and Resistance Levels You Should KnowFree Deep Market Trend Analysis - Newser
Bank of New York Mellon Corp Increases Stock Holdings in Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World
Is Arcus Biosciences Inc. stock a good hedge against inflationFree Stock Market Insider Analysis - Newser
What drives Arcus Biosciences Inc. stock priceExplosive earnings growth - printweek.in
Arcus Biosciences shares rise 3.65% intraday after granting new employee options and restricted stock units. - AInvest
Arcus Biosciences Inc. Stock Analysis and ForecastMarket-beating performance - PrintWeekIndia
Arcus Biosciences Inc (RCUS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.94%
자본화:
|
볼륨(24시간):